News

Reuters reports that Neuralink raised another $600 million in a deal that values the company at $9 billion before the ...
This summary encompasses various health-related developments, from halting drug trials after achieving success to geopolitical implications in vaccine production. Also covered are issues like measles ...
Cortigent is developing the Stroke Recovery System to improve the recovery of arm and hand movement in people who have suffered paralysis due to stroke Spin-off will allow Vivani to focus on its ...
Elon Musk has done it again. His brain-chip company Neuralink just raised $600 million at a $9 billion valuation, marking a ...
Neuralink last year received "breakthrough device" clearance from the U.S. FDA. Three people have so far received implants ...
Elon Musk's brain-mapping venture, Neuralink, recently raised $600 million, boosting its valuation to a staggering $9 billion ...
Elon Musk’s brain-implant company, Neuralink, has raised $600 million in a recent funding round, which pushed its pre-money valuation to $9 billion, according to Semafor. This latest round follows a ...
Elon Musk’ s brain-interface company, Neuralink, has successfully secured $600 million in new funding, elevating its ...
This briefing covers health-related developments worldwide, including Sanofi's vaccine initiatives in Vietnam, Roche's ...
Elon Musk’s brain implant company Neuralink raised $600 million in a deal that values the company at $9 billion before the new cash, Semafor reported Tuesday, citing people with knowledge of the ...
(Reuters) - Elon Musk's brain implant company Neuralink raised $600 million at a valuation of $9 billion, Semafor reported on ...
Elon Musk’s Neuralink has implanted its brain-computer interface in five patients, with trials showing basic ...